Multicenter clinical investigation of visual function after bilateral implantation of two presbyopia-correcting trifocal IOLs

Session Details

Session Title: Presented Poster Session: EDOF IOLs

Venue: Poster Village: Pod 1

First Author: : R.Lapid-Gortzak THE NETHERLANDS

Co Author(s): :    A. Martinez                       

Abstract Details

Purpose:

To assess the binocular visual performance of the AcrySof IQ PanOptix and the AT LISA tri 839MP IOLs after 6 months post-operative follow up.

Setting:

Multicenter Study, Coordinating site: Dept. of Ophthalmology, Academic Medical Center, University of Amsterdam, the The Netherlands.

Methods:

A prospective, multi-center, randomized, double masked, parallel group post-market study was conducted involving the bilateral implantation of AcrySof IQ PanOptix (PanOptix) or AT LISA tri 839MP (AT LISA) IOL in 182 subjects. The binocular uncorrected intermediate (60cm), near (40cm) and distance (4m) visual acuity and binocular defocus curves were evaluated under photopic lighting conditions at 6-months post-op. Photopic & Mesopic Contrast Sensitivity and Patient Satisfaction were also assessed.

Results:

One-Hundred-and-eighty-two subjects (38% M: 62% F) with a mean age of 66 ± 9 years were implanted bilaterally with either the PanOptix IOL (n=93) or the AT LISA IOL (n=89). A difference of -0.06logMAR Binocular UCIVA favored the PanOptix (p<0.002); better UCNVA (-0.05logMAR) was found in the PanOptix group (p<0.003). UCDVA was not inferior for the PanOptix group (0.01logMAR). The Mean Defocus curve VA from 0.00D to -3.00D ranged from 0.1 to 0.0 logMAR in both groups. Higher average VA scores were seen in the PanOptix group at -1.50D and -2.00D. Contrast Sensitivity and Patient Satisfaction scores were similar

Conclusions:

The AcrySof IQ PanOptix IOL was found to be superior in UCIVA & UCNVA and non-inferior in UCDVA to the AT LISA tri 839MP. Differences in defocus curves validate the optical design differences between IOLs with high patient satisfaction scores achieved in both groups.

Financial Disclosure:

... is employed by a for-profit company with an interest in the subject of the presentation, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, ... receives consulting fees, retainer, or contract payments from a competing company, ... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented